Journal
Scientific Reports
Publication Date
6-12-2024
Volume
14
Issue
1
First Page
13462
Document Type
Open Access Publication
DOI
10.1038/s41598-024-64260-9
Rights and Permissions
Prasanth, M.I., Wannigama, D.L., Reiersen, A.M. et al. A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications. Sci Rep 14, 13462 (2024). https://doi.org/10.1038/s41598-024-64260-9 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Prasanth, Mani Iyer; Wannigama, Dhammika Leshan; Reiersen, Angela Michelle; Thitilertdecha, Premrutai; Prasansuklab, Anchalee; Tencomnao, Tewin; Brimson, Sirikalaya; and Brimson, James Michael, "A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and long-COVID complications." Scientific Reports. 14, 1. 13462 (2024).
https://digitalcommons.wustl.edu/oa_4/4038
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
Author Correction
